Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Apyx Medical (APYX) Shares Issued (2016 - 2025)

Apyx Medical (APYX) has disclosed Shares Issued for 6 consecutive years, with $9.3 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Shares Issued changed N/A year-over-year to $9.3 million, compared with a TTM value of $9.3 million through Dec 2025, changed N/A, and an annual FY2025 reading of $9.3 million, changed N/A over the prior year.
  • Shares Issued was $9.3 million for Q4 2025 at Apyx Medical, up from -$500000.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $9.3 million in Q4 2025 and bottomed at -$500000.0 in Q3 2023.